Keenova Therapeutics plc Unrecognized Tax Benefits, Decrease Resulting from Acquisition
Keenova Therapeutics plc reported Unrecognized Tax Benefits, Decrease Resulting from Acquisition of $7.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition · last filed 2026-04-15
- Keenova Therapeutics plc unrecognized tax benefits, decrease resulting from acquisition for fiscal 2025 was $7.40M.
- Keenova Therapeutics plc unrecognized tax benefits, decrease resulting from acquisition for fiscal 2024 was $0.00.
- Keenova Therapeutics plc unrecognized tax benefits, decrease resulting from acquisition for fiscal 2018 was $11.80M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Acquisition 12 month |
|---|---|
| 2025-12-31 | $7.40M 10-K · filed 2026-04-15 |
| 2024-12-27 | $0.00 10-K · filed 2026-04-15 |
| 2018-12-28 | $11.80M 10-K · filed 2020-02-26 |